The pandemic marks another grim milestone: 1 in 500 Americans have died of covid-19 By Dan Keatin , Akilah Johnson and Monica Ulmanu Updated Sept. 15 at 9:00 a.m.Originally published Sept. 15, 2021 At a certain point, it was no longer a matter of if the United States would reach the gruesome milestone of 1 in 500 people dying…
Epidemiology, etiology and treatment of gastroparesis: real-world evidence from a large US national claims database Y. Ye et al. Background & Aims While gastroparesis carries a considerable healthcare and patient burden, associated epidemiological data are limited. To provide new real-world evidence for gastroparesis, we estimated disease prevalence, and investigated patient demographics and disease etiology in…
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease Daniel C. Baumgart et al. Crohn’s disease and ulcerative colitis, together referred to as inflammatory bowel disease (IBD), are chronic systemic inflammatory disorders.1 These conditions target primarily the gastrointestinal tract but can affect many organ systems through extraintestinal manifestations (e.g., peripheral and axial arthritis, episcleritis, primary…
Flawed ivermectin preprint highlights challenges of COVID drug studies The study’s withdrawal from a preprint platform deals a blow to the anti-parasite drug’s chances as a COVID treatment, researchers say. Sara Reardon “Before its withdrawal, the paper was viewed more than 150,000 times, cited more than 30 times and included in a number of meta-analyses…
Covid-19: ivermectina alla prova Pubblicato martedì 21 Settembre 2021 Sulla base delle prove attuali, non c’è sufficiente certezza sull’efficacia e la sicurezza dell’ivermectina per trattare o prevenire il covid-19. Questo in base a una revisione Cochrane di cui si è parlato molto nelle ultime settimane. L’ivermectina è un farmaco usato per trattare i parassiti, per esempio…
GRADE notes: How to use GRADE when there is “no” evidence? A case study of the expert evidence approach Reem A. Mustafa et al. Abstract Objectives One essential requirement of trustworthy guidelines is that they should be based on systematic reviews of the best available evidence. The GRADE Working Group has provided guidance for evaluating…